Agilent Technologies Inc (Agilent) is a provider of analyzing instruments, reagents, and consumables for laboratory processes. It also offers allied software and services. The company is primarily focused on scientific research, patient diagnostics, and safety testing for water, food, and pharmaceuticals. Its product portfolio includes mass spectrometry, microarray solutions, flow cytometry, vacuum technologies and others. Agilent caters to varied industries, including contract research organizations (CROs), contract manufacturing organizations (CMOs), pharmaceuticals, diagnostics, applied materials, and chemicals. The company has a significant presence across the world, with sales offices, logistics centers, R&D centers and business facilities. It commercializes its products through a network of direct sales agents, distributors, resellers, manufacturers' representatives and electronic commerce. Agilent is headquartered in Santa Clara, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Agilent Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Agilent Technologies Inc Company Overview
- Agilent Technologies Inc Company Snapshot
- Agilent Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
- Agilent Technologies Inc - Pipeline Analysis Overview
- Business Description
- Agilent Technologies Inc - Key Facts
- Agilent Technologies Inc - Major Products and Services
- Agilent Technologies Inc Pipeline Products by Development Stage
- Agilent Technologies Inc Pipeline Products Overview
- Agilent Dako SARS-CoV-2 IgG ELISA Kit
- Agilent Dako SARS-CoV-2 IgG ELISA Kit Product Overview
- Amgen Companion Diagnostic Test - Gastroesophageal Cancer
- Amgen Companion Diagnostic Test - Gastroesophageal Cancer Product Overview
- Bioenergetic Health Index Test
- Bioenergetic Health Index Test Product Overview
- Companion Diagnostic Assay - Cancer
- Companion Diagnostic Assay - Cancer Product Overview
- Companion Diagnostic PD-L1 Test
- Companion Diagnostic PD-L1 Test Product Overview
- Companion Diagnostic Test - IQFISH Hybridization
- Companion Diagnostic Test - IQFISH Hybridization Product Overview
- Companion Diagnostic Test - Pemigatinib
- Companion Diagnostic Test - Pemigatinib Product Overview
- Companion Diagnostic Test - INCA32459
- Companion Diagnostic Test - INCA32459 Product Overview
- Companion Diagnostic Test - INCA33890
- Companion Diagnostic Test - INCA33890 Product Overview
- Companion Diagnostic Test - INCAGN2385
- Companion Diagnostic Test - INCAGN2385 Product Overview
- Companion Diagnostic Test - INCAGN2390
- Companion Diagnostic Test - INCAGN2390 Product Overview
- Companion Diagnostic Test - INCB123667
- Companion Diagnostic Test - INCB123667 Product Overview
- Companion Diagnostic Test - INCB161734
- Companion Diagnostic Test - INCB161734 Product Overview
- Companion Diagnostic Test - INCB99280
- Companion Diagnostic Test - INCB99280 Product Overview
- Companion Diagnostic Test - INCB99318
- Companion Diagnostic Test - INCB99318 Product Overview
- Companion Diagnostic Test - Itacitinib
- Companion Diagnostic Test - Itacitinib Product Overview
- Companion Diagnostic Test - Retifanlimab
- Companion Diagnostic Test - Retifanlimab Product Overview
- Companion Diagnostic Test - Tafasitamab
- Companion Diagnostic Test - Tafasitamab Product Overview
- Diagnostic Test - Neurological Diseases
- Diagnostic Test - Neurological Diseases Product Overview
- Electron Capture Dissociation Based Diagnostic Tool
- Electron Capture Dissociation Based Diagnostic Tool Product Overview
- MET4 PharmDx Companion Diagnostic Assay - Cancer
- MET4 PharmDx Companion Diagnostic Assay - Cancer Product Overview
- Next Generation Sequencing System - Pathogen Identification
- Next Generation Sequencing System - Pathogen Identification Product Overview
- Resolution CtDx FIRST Assay
- Resolution HRD Assay
- Resolution HRD Assay Product Overview
- VeriTag C. Difficile Drug Resistance Diagnostic Test
- VeriTag C. Difficile Drug Resistance Diagnostic Test Product Overview
- VeriTag Drug Resistance Diagnostic Test - Influenza
- VeriTag Drug Resistance Diagnostic Test - Influenza Product Overview
- VeriTag Drug Resistance Diagnostic Test - MRSA
- VeriTag Drug Resistance Diagnostic Test - MRSA Product Overview
- VeriTag HBV Drug Resistance Diagnostic Test
- VeriTag HBV Drug Resistance Diagnostic Test Product Overview
- VeX-HCV Assay
- VeX-HCV Assay Product Overview
- VeX-HIV Assay
- VeX-HIV Assay Product Overview
- Agilent Technologies Inc - Key Competitors
- Agilent Technologies Inc - Key Employees
- Agilent Technologies Inc - Key Employee Biographies
- Agilent Technologies Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Agilent Technologies Inc, Recent Developments
- May 22, 2024: Agilent at ASMS 2024: Driving Scientific Breakthroughs with Unparalleled Mass Spec Solutions
- Apr 15, 2024: Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
- Feb 21, 2024: Agilent CEO Mike McMullen to Retire; Agilent CrossLab Group President Padraig McDonnell Named CEO-Elect
- Jan 16, 2024: Agilent Announces New ProteoAnalyzer System
- Jan 16, 2024: MSD Highlights Biomarker Testing To Deliver Gastric Cancer Immunotherapy
- Nov 14, 2023: Agilent Receives FDA Approval for PD-L1 IHC 22C3 Pharmdx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
- Nov 07, 2023: FDA Amends Pembrolizumab’s Gastric Cancer Indication
- Oct 06, 2023: Agilent and Sarawak Infectious Disease Centre Partner to Boost Neglected Tropical Diseases Research in East Malaysia
- Sep 19, 2023: Agilent and NCCS Sign Research Collaboration Agreement to Advance Singapore’s Genomic Profiling on Asian-prevalent Cancers
- Aug 24, 2023: Agilent Receives European IVDR Certification For Companion Diagnostic Assay
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Agilent Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
- Agilent Technologies Inc Pipeline Products by Equipment Type
- Agilent Technologies Inc Pipeline Products by Indication
- Agilent Technologies Inc, Key Facts
- Agilent Technologies Inc, Major Products and Services
- Agilent Technologies Inc Number of Pipeline Products by Development Stage
- Agilent Technologies Inc Pipeline Products Summary by Development Stage
- Agilent Dako SARS-CoV-2 IgG ELISA Kit - Product Status
- Agilent Dako SARS-CoV-2 IgG ELISA Kit - Product Description
- Amgen Companion Diagnostic Test - Gastroesophageal Cancer - Product Status
- Amgen Companion Diagnostic Test - Gastroesophageal Cancer - Product Description
- Bioenergetic Health Index Test - Product Status
- Bioenergetic Health Index Test - Product Description
- Companion Diagnostic Assay - Cancer - Product Status
- Companion Diagnostic Assay - Cancer - Product Description
- Companion Diagnostic PD-L1 Test - Product Status
- Companion Diagnostic PD-L1 Test - Product Description
- Companion Diagnostic Test - IQFISH Hybridization - Product Status
- Companion Diagnostic Test - IQFISH Hybridization - Product Description
- Companion Diagnostic Test - Pemigatinib - Product Status
- Companion Diagnostic Test - Pemigatinib - Product Description
- Companion Diagnostic Test - INCA32459 - Product Status
- Companion Diagnostic Test - INCA32459 - Product Description
- Companion Diagnostic Test - INCA33890 - Product Status
- Companion Diagnostic Test - INCA33890 - Product Description
- Companion Diagnostic Test - INCAGN2385 - Product Status
- Companion Diagnostic Test - INCAGN2385 - Product Description
- Companion Diagnostic Test - INCAGN2390 - Product Status
- Companion Diagnostic Test - INCAGN2390 - Product Description
- Companion Diagnostic Test - INCB123667 - Product Status
- Companion Diagnostic Test - INCB123667 - Product Description
- Companion Diagnostic Test - INCB161734 - Product Status
- Companion Diagnostic Test - INCB161734 - Product Description
- Companion Diagnostic Test - INCB99280 - Product Status
- Companion Diagnostic Test - INCB99280 - Product Description
- Companion Diagnostic Test - INCB99318 - Product Status
- Companion Diagnostic Test - INCB99318 - Product Description
- Companion Diagnostic Test - Itacitinib - Product Status
- Companion Diagnostic Test - Itacitinib - Product Description
- Companion Diagnostic Test - Retifanlimab - Product Status
- Companion Diagnostic Test - Retifanlimab - Product Description
- Companion Diagnostic Test - Tafasitamab - Product Status
- Companion Diagnostic Test - Tafasitamab - Product Description
- Diagnostic Test - Neurological Diseases - Product Status
- Diagnostic Test - Neurological Diseases - Product Description
- Electron Capture Dissociation Based Diagnostic Tool - Product Status
- Electron Capture Dissociation Based Diagnostic Tool - Product Description
- MET4 PharmDx Companion Diagnostic Assay - Cancer - Product Status
- MET4 PharmDx Companion Diagnostic Assay - Cancer - Product Description
- Next Generation Sequencing System - Pathogen Identification - Product Status
- Next Generation Sequencing System - Pathogen Identification - Product Description
- Resolution CtDx FIRST Assay - Product Description
- Resolution HRD Assay - Product Status
- Resolution HRD Assay - Product Description
- VeriTag C. Difficile Drug Resistance Diagnostic Test - Product Status
- VeriTag C. Difficile Drug Resistance Diagnostic Test - Product Description
- VeriTag Drug Resistance Diagnostic Test - Influenza - Product Status
- VeriTag Drug Resistance Diagnostic Test - Influenza - Product Description
- VeriTag Drug Resistance Diagnostic Test - MRSA - Product Status
- VeriTag Drug Resistance Diagnostic Test - MRSA - Product Description
- VeriTag HBV Drug Resistance Diagnostic Test - Product Status
- VeriTag HBV Drug Resistance Diagnostic Test - Product Description
- VeX-HCV Assay - Product Status
- VeX-HCV Assay - Product Description
- VeX-HIV Assay - Product Status
- VeX-HIV Assay - Product Description
- Agilent Technologies Inc, Key Employees
- Agilent Technologies Inc, Key Employee Biographies
- Agilent Technologies Inc, Subsidiaries
- Glossary
- Agilent Technologies Inc Pipeline Products by Equipment Type
- Agilent Technologies Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Roche Tissue Diagnostics
- Natera Inc
- Cytek Biosciences Inc
- Twist Bioscience Corp
- Danaher Corp
- Revvity Inc
- Illumina Inc
- Thermo Fisher Scientific Inc
- Abbott Laboratories
- Waters Corp
- Shimadzu Corp
- Affymetrix, Inc.
